shortagewatch

Home / Companies / Accord (Intas)

Company family · HQ IN

Accord (Intas): medicine shortages

private (Intas Pharmaceuticals)

As of 2 Nov 2026, 484 Accord (Intas) products have a reported shortage across 13 countries, covering 151 medicines.

Products short484rank #5 of 464
Medicines151active ingredients
Countries13/16
New in 90 days107+10 vs market pace
Typical duration8 monthsmedian so far
Manufacturing59%demand-driven 28%

Where

United States26Canada55Germany9France4Italy158Spain40Ireland49Austria7Belgium28Switzerland1Czechia27Norway10Sweden70

Which therapeutic classes

Cancer and immune system161Nervous system138Cardiovascular system53Digestive tract and metabolism43Anti-infectives25Genito-urinary system and sex hormones20Systemic hormones17Blood9Musculoskeletal system8Respiratory system4

Why, compared with all companies

Manufacturing problemIncreased demandActive ingredient shortageDistribution or logisticsCommercial decision or withdrawalRegulatory or licensingOtherNot stated
Accord (Intas)Accord (Intas): Manufacturing problem 209 (44%)44%Accord (Intas): Increased demand 98 (21%)21%Accord (Intas): Distribution or logistics 9 (2%)Accord (Intas): Commercial decision or withdrawal 26 (5%)5%Accord (Intas): Regulatory or licensing 5 (1%)Accord (Intas): Other 3 (1%)Accord (Intas): Not stated 128 (27%)27%All companiesAll companies: Manufacturing problem 4,893 (36%)36%All companies: Increased demand 1,873 (14%)14%All companies: Active ingredient shortage 367 (3%)All companies: Distribution or logistics 336 (2%)All companies: Commercial decision or withdrawal 435 (3%)All companies: Regulatory or licensing 131 (1%)All companies: Other 1,244 (9%)9%All companies: Not stated 4,221 (31%)31%

Manufacturing problems point to the company's own supply chain; increased demand often follows a competitor's shortage or a demand shock.

When its current shortages began

0255075100Dec: 9Jan ’25: 5Feb: 7FebMar: 2Apr: 3May: 5MayJun: 5Jul: 8Aug: 4AugSep: 5Oct: 10Nov: 3NovDec: 6Jan ’26: 4Feb: 22FebMar: 21Apr: 54May: 14MayJun: 13Jul: 22Aug: 23AugSep: 32Oct: 55Nov: 0Nov

Long-run trend in Canada

Canada dashboard
0501001502002017: 2820172018: 1020182019: 1820192020: 1220202021: 620212022: 5920222023: 11620232024: 9320242025: 3620252026: 82026

Canada publishes every report since 2017, so it shows whether this company is reporting more or fewer shortages over time. The current year is partial.

Against its peers

Viatris995Teva903Sandoz599Pfizer491Accord (Intas)484Stada349Zentiva340Fresenius Kabi339Apotex326Sun Pharma250Aurobindo226Towa (Pensa)201Krka187Sanofi158Jamp151

Breadth vs depth

1101001,00010,0001101001,000Products short (log scale)Medicines affected (log scale)Viatris: 995 / 248ViatrisTeva: 903 / 289TevaSandoz: 599 / 198SandozPfizer: 491 / 122PfizerStada: 349 / 140Zentiva: 340 / 159ZentivaFresenius Kabi: 339 / 81Apotex: 326 / 152Sun Pharma: 250 / 77Aurobindo: 226 / 111Towa (Pensa): 201 / 102Krka: 187 / 67Sanofi: 158 / 45Jamp: 151 / 74Baxter: 149 / 27Sawai: 148 / 68Hikma: 126 / 44Glenmark: 105 / 39Sanis: 98 / 54Cheplapharm: 86 / 28GSK: 85 / 38Advanz (Amdipharm): 81 / 24Nichi-Iko: 77 / 29Takeda: 76 / 10Johnson & Johnson: 75 / 19Neuraxpharm: 75 / 19Novartis: 70 / 32Bayer: 68 / 17Biomed: 64 / 21Daiichi Sankyo: 59 / 18Orifarm: 59 / 40Medochemie: 56 / 14Pharmascience: 51 / 32Marcan: 51 / 16Doc Generici: 50 / 25B. Braun: 49 / 17AA Pharma: 46 / 26H E: 46 / 15Octapharma: 42 / 6Jv E: 42 / 1Kyowa Pharmaceutical: 42 / 16Novo Nordisk: 41 / 8Odan: 41 / 31Aspen: 41 / 13Sterop: 41 / 16Nipro: 41 / 17Dr. Reddy's: 40 / 24Organon: 40 / 20Laboratoire Riva: 40 / 23Kern Pharma: 40 / 30Bausch Health: 39 / 30Bracco: 38 / 6G.L.: 38 / 13Tatsumi Kagaku: 38 / 24Otsuka: 37 / 4Eli Lilly: 37 / 12Piramal Critical: 35 / 13Imuna Pharm: 35 / 4AbbVie: 34 / 15Medical Valley: 34 / 8Orion: 34 / 24Rowex: 34 / 19Takata Pharmaceutical: 33 / 17Aristo: 32 / 16Norgine: 32 / 3Gedeon Richter: 31 / 11Eql: 31 / 9Guerbet: 30 / 5Lukas Heil-Betriebsst: 30 / 0Roche: 29 / 14Omega: 29 / 18Bgp: 29 / 18Holsten -: 29 / 3Menarini: 29 / 17Paladin: 28 / 17Grifols: 28 / 9Ge: 28 / 6Merck & Co. (MSD): 27 / 14Ferring: 27 / 7Accord (Intas): 484 / 151Accord (Intas)

Further right: more products short. Higher: more different medicines affected.

Medicines short

MedicineWhere this company is shortProductsEarliest startMain reasonShort anywhere
Quetiapine3223 Jan 2023Manufacturing problem12/16
Atomoxetine181 Nov 2023Manufacturing problem11/16
Cinacalcet152 Jul 2024Manufacturing problem11/16
Lacosamide1422 Sep 2022Manufacturing problem6/16
Aprepitant1015 Jan 2024Manufacturing problem12/16
Carboplatin928 Apr 2023Increased demand10/16
Doxorubicin931 Aug 2023Manufacturing problem8/16
Lenalidomide928 Jun 2023Manufacturing problem10/16
Levetiracetam931 May 2022Increased demand9/16
Oxaliplatin824 Feb 2025Manufacturing problem10/16
Cytarabine71 Jun 2025Not stated8/16
Methotrexate725 Apr 2022Not stated6/16
Oxycodone716 Oct 2024Not stated6/16
Sitagliptin727 Jun 2023Manufacturing problem8/16
Tadalafil724 Apr 2026Increased demand10/16
Temozolomide714 Jan 2022Manufacturing problem6/16
Atropine61 Jan 2012Manufacturing problem5/16
Clonazepam610 Mar 2023Not stated4/16
Docetaxel615 Mar 2026Not stated8/16
Paclitaxel630 May 2022Manufacturing problem7/16
Pioglitazone627 Oct 2023Manufacturing problem7/16
Pregabalin630 Jun 2022Increased demand11/16
Sildenafil624 Apr 2026Increased demand10/16
Atorvastatin56 Mar 2026Increased demand11/16
Fluorouracil525 Feb 2026Not stated7/16
Fluoxetine524 Jul 2024Manufacturing problem8/16
Mitomycin51 Dec 2019Not stated7/16
Pemetrexed522 Feb 2024Manufacturing problem6/16
Candesartan425 Apr 2019Manufacturing problem10/16
Epirubicin429 May 2026Manufacturing problem7/16
Escitalopram425 Jan 2022Increased demand10/16
Etoposide414 Aug 2026Increased demand7/16
Filgrastim427 Aug 2026Manufacturing problem4/16
Fluconazole41 Apr 2026Commercial decision or withdrawal12/16
Furosemide47 Apr 2020Manufacturing problem11/16
Gabapentin45 May 2023Manufacturing problem9/16
Gemcitabine46 Oct 2024Manufacturing problem9/16
Montelukast424 Jul 2024Not stated13/16
Mycophenolic Acid414 Feb 2022Manufacturing problem6/16
Simvastatin and Ezetimibe419 Mar 2024Increased demand8/16
Ustekinumab428 May 2026Manufacturing problem4/16
Bendamustine326 Feb 2026Not stated7/16
Bisoprolol31 Apr 2026Increased demand6/16
Bupropion324 Oct 2024Manufacturing problem7/16
Capecitabine311 Feb 2026Manufacturing problem6/16
Clozapine320 Apr 2022Manufacturing problem3/16
Dabigatran Etexilate325 Jan 2024Not stated10/16
Dexmedetomidine310 Apr 2020Manufacturing problem4/16
Donepezil35 Nov 2025Manufacturing problem8/16
Ezetimibe314 Jan 2022Manufacturing problem9/16
Fingolimod34 Mar 2022Not stated9/16
Glimepiride31 Feb 2026Increased demand5/16
Imatinib322 Mar 2024Manufacturing problem6/16
Lidocaine328 Dec 2025Commercial decision or withdrawal9/16
Methotrexate329 Jul 2026Not stated6/16
Olmesartan Medoxomil330 Oct 2025Increased demand5/16
Palonosetron320 Sep 2026Not stated5/16
Plerixafor313 Feb 2026Not stated7/16
Posaconazole39 Jul 2026Not stated6/16
Pravastatin328 Jun 2024Manufacturing problem6/16
Rivaroxaban315 Oct 2026Manufacturing problem13/16
Spironolactone316 Oct 2023Not stated4/16
Topotecan38 Jan 2025Manufacturing problem5/16
Vinorelbine312 Mar 2026Not stated5/16
Allopurinol210 Mar 2026Increased demand9/16
Amlodipine230 Sep 2025Increased demand8/16
Anastrozole221 Aug 2025Increased demand5/16
Atenolol28 Apr 2026Increased demand6/16
Azacitidine221 Dec 2020Not stated6/16
Bicalutamide214 Jan 2022Manufacturing problem6/16
Carmustine214 Apr 2026Not stated3/16
Ciprofloxacin217 Dec 2024Increased demand9/16
Colistin230 Apr 2025Manufacturing problem6/16
Deferasirox214 Aug 2025Manufacturing problem8/16
Denosumab226 Jun 2026Increased demand2/16
Eplerenone224 Mar 2026Increased demand6/16
Fulvestrant231 May 2026Commercial decision or withdrawal5/16
Icatibant224 Mar 2026Increased demand8/16
Irbesartan224 Apr 2026Increased demand6/16
Levosimendan225 Jun 2025Manufacturing problem4/16
Losartan21 Dec 2025Commercial decision or withdrawal6/16
Lurasidone230 Oct 2026Manufacturing problem2/16
Ondansetron28 May 2026Increased demand9/16
Oxybutynin230 Jun 2025Manufacturing problem5/16
Pantoprazole227 Feb 2026Increased demand9/16
Pazopanib226 Oct 2026Not stated4/16
Propafenone224 Apr 2026Increased demand3/16
Sertraline222 Oct 2025Increased demand11/16
Solifenacin29 May 2024Manufacturing problem6/16
Sumatriptan23 Feb 2026Manufacturing problem13/16
Teicoplanin219 Oct 2026Manufacturing problem5/16
Tenofovir Disoproxil221 May 2025Not stated6/16
Teriflunomide228 Jun 2024Manufacturing problem4/16
Teriparatide230 Aug 2026Manufacturing problem5/16
Tolterodine28 Jan 2025Quality problem or recall8/16
Tolvaptan229 Jun 2026Manufacturing problem2/16
Topiramate224 Feb 2023Manufacturing problem8/16
Aceclofenac131 Mar 2026Increased demand3/16
Aciclovir123 Sep 2026Not stated6/16
Alendronic Acid112 Jul 2024Manufacturing problem7/16
Amifampridine123 Nov 2026Manufacturing problem1/16
Apremilast11 Dec 2026Increased demand5/16
Axitinib129 Oct 2026Not stated2/16
Azithromycin130 Apr 2026Commercial decision or withdrawal9/16
Betahistine18 Sep 2024Manufacturing problem5/16
Bortezomib120 Sep 2026Not stated5/16
Bosentan130 Sep 2026Manufacturing problem7/16
Celecoxib13 Feb 2026Manufacturing problem1/16
Clofarabine130 Mar 2026Not stated1/16
Dalbavancin19 Oct 2026Increased demand2/16
Daptomycin123 Oct 2023Manufacturing problem5/16
Diazepam112 Aug 2024Not stated7/16
Dimethyl Fumarate11 Jul 2026Manufacturing problem5/16
Duloxetine112 Apr 2024Not stated12/16
Entecavir11 Oct 2026Distribution or logistics8/16
Eptifibatide119 Oct 2026Manufacturing problem2/16
Eslicarbazepine16 Jul 2026Increased demand1/16
Exemestane112 Oct 2026Increased demand3/16
Finasteride124 Apr 2026Increased demand2/16
Finasteride124 Apr 2026Increased demand8/16
Fludarabine120 Oct 2026Not stated3/16
Gentamicin11 Mar 2026Commercial decision or withdrawal1/16
Ibandronic Acid128 Jul 2026Manufacturing problem4/16
Ibuprofen123 Apr 2026Manufacturing problem8/16
Interferon Alfacon-116 Nov 2026Increased demand1/16
Irinotecan127 Nov 2026Manufacturing problem5/16
Ivabradine110 Sep 2025Increased demand9/16
Lercanidipine11 Sep 2026Increased demand4/16
Letrozole119 Oct 2026Increased demand6/16
Linezolid121 Jan 2026Not stated7/16
Memantine124 Apr 2026Increased demand8/16
Metoclopramide120 Sep 2026Not stated6/16
Midazolam131 Aug 2026Distribution or logistics7/16
Miglustat128 Feb 2022Manufacturing problem2/16
Naltrexone118 May 2026Increased demand2/16
Nebivolol11 Mar 2026Commercial decision or withdrawal4/16
Olanzapine11 Apr 2026Manufacturing problem13/16
Olmesartan Medoxomil and Amlodipine124 Apr 2026Increased demand4/16
Omeprazole112 Apr 2024Manufacturing problem8/16
Paracetamol115 Oct 2024Not stated10/16
Pirfenidone11 Dec 2025Commercial decision or withdrawal6/16
Pomalidomide11 Jun 2026Manufacturing problem6/16
Ritonavir110 Aug 2026Not stated6/16
Sorafenib13 Sep 2026Not stated6/16
Sugammadex11 Jun 2026Commercial decision or withdrawal6/16
Sunitinib116 Jul 2026Not stated5/16
Tigecycline12 Oct 2026Manufacturing problem2/16
Trabectedin131 Aug 2026Manufacturing problem6/16
Valganciclovir118 Sep 2026Increased demand5/16
Vildagliptin115 Jan 2025Not stated3/16
Voriconazole127 Oct 2025Commercial decision or withdrawal6/16

Shortage data describes supply, not company finances. A shortage can mean lost sales for the supplier or extra demand for its competitors. Nothing here is investment advice; tickers are for identification only and may be out of date.